Cecilia Brown

Associate Editor

Cecilia Brown is an Associate Editor for Blood Cancers Today.

Articles by Cecilia Brown

Cecilia BrownAcute Myeloid Leukemia | September 21, 2023
The study was conducted because it was “uncertain whether a fractionated schedule provides additional benefit."
Read More
Cecilia BrownAcute Myeloid Leukemia | September 21, 2023
Researchers analyzed prognostic impact of NPM1 MRD in a real-world cohort of patients with NPM1-mutated AML.
Cecilia BrownAcute Myeloid Leukemia | September 21, 2023
The primary endpoints were short-term event-free survival and overall survival in the intention-to-treat population.
Cecilia BrownAcute Lymphoblastic Leukemia | September 20, 2023
Researchers retrospectively analyzed treatment outcomes of 69 patients with relapsed or refractory CRLF2-rearranged B-ALL.
Cecilia BrownAcute Lymphoblastic Leukemia | September 20, 2023
Low hypodiploidy “defines a rare subtype” of B-cell ALL with a “dismal outcome.”
Cecilia BrownAcute Myeloid Leukemia | September 20, 2023
The retrospective, observational study included adults who received their first allogeneic HSCT during their first remission.
Cecilia BrownChronic Lymphocytic Leukemia | September 20, 2023
Dr. Coombs discusses her journey into oncology, what it’s like to broach the lymphoid and myeloid worlds, and a unique ...
Cecilia BrownMyelodysplastic Syndromes | September 14, 2023
The proof-of-concept study showed that noninvasive hemoglobin measurement is “feasible,” but there were several ...
Cecilia BrownMeeting News | September 14, 2023
One aim is to evaluate the efficacy of oral decitabine/cedazuridine and magrolimab in intermediate to HR MDS.
Cecilia BrownChronic Lymphocytic Leukemia | September 11, 2023
All patients included in the study required treatment and had not previously received psychiatric treatment.
Cecilia BrownMeeting News | September 11, 2023
The study included patients with relapsed or refractory B-cell malignancies who were in the phase I/II BRUIN trial.
Cecilia BrownChronic Lymphocytic Leukemia | September 11, 2023
The researchers investigated if iso-cel in patients with relapsed or refractory CLL is a cost-efficient option.
Cecilia BrownMeeting News | September 9, 2023
Patients with MPNs faced higher direct and indirect costs and were significantly more likely to take disability leave.
Cecilia BrownMyeloproliferative Neoplasms | September 9, 2023
Researchers presented data from the randomized withdrawal phase of the study at the SOHO Annual Meeting.
Cecilia BrownMeeting News | September 9, 2023
Researchers sought to differentiate the mechanism of action of luspatercept from epoetin alfa.
Cecilia BrownMantle Cell Lymphoma | September 8, 2023
The patient cohort had median OS of 27 months and a five-year OS of 24.5%.
Cecilia BrownMeeting News | September 7, 2023
The award recognizes a SOHO member who has significantly contributed to the advancement of blood cancer care and research.
Cecilia BrownChronic Lymphocytic Leukemia | September 7, 2023
Dr. Brown shares what CLL news and session she's watching at the Eleventh Annual Meeting of SOHO.
Cecilia BrownMeeting News | September 7, 2023
Multiple posters received awards from the Society during a ceremony held at the annual meeting.
Jennifer R. Brown, MD, PhDMeeting News | September 6, 2023
SOHO President Jennifer Brown, MD, PhD, talks about why she chose personalized medicine as this year's theme.